English | 简体中文 | 繁體中文 | 한국어
Share:
Kitron CEO Peter Nilsson on medical leave

(2019-01-03) Kitron ASA's President and Chief Executive Officer Peter Nilsson will be undergoing treatment for a type of cancer and is expected to be on leave of absence until the end of June 2019, after which he will resume his duties.

Effective today, Chief Financial Officer Cathrin Nylander will be acting President and Chief Executive Officer. Ms. Nylander has been the CFO of Kitron since August 2013.

"The board wishes Peter a speedy recovery and look forward to his return in the summer. In the meantime, we know that Cathrin and the rest of the management team will do an excellent job implementing the ambitious plans for 2019," said Tuomo Lähdesmäki, Chairman of the Board of Kitron ASA.

For further information, please contact:
Tuomo Lähdesmäki, Chairman of the Board, tel: +358 50 5879648
Cathrin Nylander, Acting President and CEO, tel: +47 900 43 284
E-mail: [email protected]

Kitron is one of Scandinavia's leading electronics manufacturing services companies for the Energy/Telecoms, Industry, Defence, Medical devices and Offshore/Marine sectors. The company is located in Norway, Sweden, Lithuania, Germany, China and the United States. Kitron had revenues of approx. NOK 2.4 billion in 2017 and has about 1,450 employees. www.kitron.com

This information is subject to the disclosure requirements set out in section 5 -12 of the Norwegian Securities Trading Act, and section 3-4 of the Oslo Stock Exchange continuing obligations for listed companies.




This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Kitron ASA via Globenewswire

Copyright © Thomson Reuters 2019. All rights reserved.
Press Releases
FRO - Update Regarding Front Altair  
June 14, 2019 21:30 ET
Novartis continues to innovate in CML with long-term treatment-free remission results following Tasigna® use and promising combination data with investigational compound asciminib (ABL001)  
June 14, 2019 08:30 ET
Ole Martin Grimsrud Appointed CFO of Aker Solutions  
June 14, 2019 07:00 ET
REC Silicon - Delay Moses Lake shutdown decision until July 15  
June 13, 2019 21:00 ET
DFDS A/S: COLLABORATION WITH VOLVO TRUCKS ON AUTONOMOUS TRANSPORT BETWEEN LOGISTICS CENTRE AND PORT TERMINAL  
June 13, 2019 15:43 ET
Verisk Financial Helps Neobank Xinja Ensure APRA Compliance  
June 4, 2019 22:29 ET
Curt Espeland to address the Deutsche Bank Global Industrials & Materials Summit  
May 30, 2019 22:29 ET
Lubrizol to Present at the 29th CIMAC World Congress 2019  
May 28, 2019 21:59 ET
Particle Sciences Expands Controlled Substance Capabilities with Approval of DEA Schedule I Registration  
May 28, 2019 20:29 ET
Forbes ranks Eastman as one of the Best Large Employers in America  
May 21, 2019 22:29 ET
More News >>
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: